Inogen to Participate in Upcoming Investor Conferences
GOLETA, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that the Company's management will be participating in two upcoming investor conferences.
Inogen's CEO, Ray Huggenberger and CFO, Alison Bauerlein are scheduled to present at the J.P. Morgan 33rd Annual Healthcare Conference in San Francisco on Monday, January 12 at 4:00pm PT.
Inogen's Executive Vice President of Sales and Marketing, Scott Wilkinson, is scheduled to present at the 17th Annual Needham Growth Conference in New York City on January 14 at 8:40am ET.
Interested parties can access the live audio webcast for both of these conference presentations from the Events section of the Investor Relations page on the Inogen website at www.inogen.com. Both webcast replays will be available approximately one hour after the conclusion of the live presentations and will remain available for approximately 90 days.
Inogen has used, and intends to continue to use, its Investor Relations website, www.inogen.com/investor, as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit www.inogen.com/investor.
About Inogen
Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
CONTACT: Investor Relations Contact:
ir@inogen.net
805-562-0500 ext 7
Media Contact:
Byron Myers
805-562-0503
Released December 22, 2014